Qube Research & Technologies (QRT)
ASLN

Qube Research & Technologies (QRT)’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ASLN Stock Details ASLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-4
Closed -$10 – 4371
2024
Q2 		$10 Hold
4
– – ﹤0.01% 3618
2024
Q1 		$21 Sell
4
-25
-86% -$125 ﹤0.01% 4265
2023
Q4 		$122 Hold
29
– – ﹤0.01% 4016
2023
Q3 		$433 Buy
+29
New +$532 ﹤0.01% 3690

Other funds holding ASLN

RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ASLN Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q3 2024, closing a stake of 4 shares — an estimated $10 sold.

Qube Research & Technologies (QRT) first reported a position in ASLN in Q3 2023 and held it in 4 quarters. The position peaked at $433 in Q3 2023. 1 fund tracked by Wall St. Rank holds ASLN as of Q3 2024.

  • Qube Research & Technologies (QRT) reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q3 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 4 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q3 2024, an estimated $10.
  • Qube Research & Technologies (QRT) first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q3 2023 and held it in 4 quarters.
  • Qube Research & Technologies (QRT)'s ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $433 in Q3 2023.
  • 1 fund tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.